Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status

Thorax

Volumn 69, Issue 2, 2014, Pages 168-173

  Rodrigo, Chamira ^a   Bewick, Thomas ^a   Sheppard, Carmen ^b   Greenwood, Sonia ^a   MacGregor, Vanessa ^b   Trotter, Caroline ^c   Slack, Mary ^b   George, Robert ^b   Lim, Wei Shen ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HERD IMMUNITY; HUMAN; IMMUNOASSAY; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIPLEX IMMUNOASSAY; PATHOGENESIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

PNEUMONIA; RESPIRATORY INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; IMMUNITY, HERD; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; YOUNG ADULT;

EID: 84892537461     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203987     Document Type: Article

References (35)

1. Trotter CL, Stuart JM, George R, et al. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008;14: 727-33. (Pubitemid 351838635)
2. Rodrigo C, Mckeever TM, Woodhead M, et al. Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia. Thorax 2013;68: 493-5.
3. Menendez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004;59: 960-65. (Pubitemid 39490781)
4. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012;67: 71-9.
5. Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 2011;66: 340-6.
6. Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004;4: 144-54. (Pubitemid 38293138)
7. Regev-Yochay G, Dagan R, Raz M, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 2004;292: 716-20. (Pubitemid 39062526)
8. Hussain M, Melegaro A, Pebody RG, et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 2005;133: 891-8. (Pubitemid 41478975)
9. Hill PC, Townend J, Antonio M, et al. Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis 2010;50: 1468-76.
10. Levine OS, Farley M, Harrison LH, et al. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 1999;103:e28.
11. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000;342: 681-9. (Pubitemid 30131420)
12. Breiman RF, Keller DW, Phelan MA, et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000;160: 2633-8.
13. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201: 32-41.
14. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348: 1737-46. (Pubitemid 36514704)
15. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294: 2043-51. (Pubitemid 41539937)
16. Metlay JP, Fishman NO, Joffe M, et al. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006;24: 468-75. (Pubitemid 41832550)
17. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007;369: 1179-86. (Pubitemid 46527876)
18. Nelson JC, Jackson M, Yu O, et al. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008;26: 4947-54.
19. Kristiansen BE, Tveten Y, Jenkins A. Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study. BMJ 1998;317: 621-5. (Pubitemid 28403483)
20. Sheppard CL, Harrison TG, Smith MD, et al. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples. J Med Microbiol 2011;60: 49-55.
21. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997;46(RR-8): 1-24.
22. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422.
23. Public Health England. Vaccine coverage data. http://www.hpa.org.uk/webw/ HPAweb&HPAwebStandard/HPAweb-C/12114414422882013 (cited Aug 2013).
24. Cherian T, Steinhoff MC, Harrison LH, et al. A cluster of invasive pneumococcal disease in young children in child care. JAMA 1994;271: 695-7. (Pubitemid 24061705)
25. Simonsen L, Taylor RJ, Young-Xu Y, et al. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio 2011;2:e00309-10.
26. Walter ND, Taylor TH, Dowell SF, et al. Holiday spikes in pneumococcal disease among older adults. N Engl J Med 2009;361: 2584-5.
27. Reis JN, Palma T, Ribeiro GS, et al. Transmission of Streptococcus pneumoniae in an urban slum community. J Infect 2008;57: 204-13.
28. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009;124:e1-e11.
29. Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J 2004;23: 1015-22. (Pubitemid 40824291)
30. Millar EV, Watt JP, Bronsdon MA, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 2008;47: 989-96.
31. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19: 187-95. (Pubitemid 30167436)
32. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006;368: 1495-502. (Pubitemid 44634693)
33. Melin M, Jarva H, Siira L, et al. Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun 2009;77: 676-84.
34. Sinclair A, Xie X, Teltscher M, et al. Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol 2013;51: 2303-10.
35. Briones ML, Blanquer J, Ferrando D, et al. Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clin Vaccine Immunol 2006;13: 1092-7. (Pubitemid 44622535)